ArticlePlastic and reconstructive surgery. Global open2025
Advances in Poly-l-lactic Acid Injections for Facial and Neck Rejuvenation.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Regenerative Functional Microspheres for Aesthetic Medicine: Mechanism, Materials, Fabrication, and Clinical Applications.Advanced healthcare materials · 2026Review
- Article
- Advanced on Minimally Invasive Techniques in Facial Rejuvenation: A Comprehensive Review.World journal of plastic surgery · 2026Review
- Longevity Aesthetics: A Conceptual Framework for Integrating Pro-Aging Medicine Into Surgical and Nonsurgical Practice.Aesthetic surgery journal. Open forum · 2026Article
- Poly-L-lactic acid (PLLA) in arm contouring: a prospective and blinded trial of Rennova® Elleva and Sculptra®.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poly-l-lactic acid (PLLA) has gained popularity as a cosmetic injectable filler due to its excellent biocompatibility and capacity for long-term collagen stimulation. Despite widespread clinical use, a comprehensive evaluation of recent advancements and updated clinical techniques is essential for improving facial rejuvenation outcomes and minimizing complications. Methods: A comprehensive literature review was conducted through databases including PubMed and Web of Science. We analyzed recent advancements, clinical efficacy, safety profiles, injection techniques, and comparative advantages of PLLA relative to other fillers. The review emphasized clinical trial outcomes, practical injection recommendations, and management strategies for common and rare complications. Results: Recent clinical studies confirmed the effectiveness of PLLA in treating facial wrinkles, volume loss, and enhancing skin elasticity and hydration, with patient satisfaction exceeding 90%. Novel injection techniques such as ultrasound guidance and needle-free microjet injection have improved safety and patient satisfaction. Technological innovations, including particle-size optimization and composite formulations, have further enhanced the biocompatibility, efficacy, and duration of effect of PLLA, significantly reducing adverse events. Conclusions: PLLA injections offer safe, long-lasting, and natural rejuvenation outcomes for facial and neck areas. Continuous innovation in injection technologies, particle formulations, and combination therapies promises further enhancements. Future research should focus on individualized treatment protocols, optimizing long-term safety and efficacy, and expanding PLLA applications through advanced biomaterials and regenerative approaches.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.